Biohaven Ltd.

NYSE: BHVN · Real-Time Price · USD
15.72
1.49 (10.47%)
At close: Aug 15, 2025, 3:59 PM
15.75
0.19%
After-hours: Aug 15, 2025, 07:51 PM EDT

Biohaven Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 3.84M n/a n/a n/a n/a n/a n/a n/a -215.08M n/a 215.08M 318.85M 190.01M 135.74M 92.93M 43.82M
Cost of Revenue
n/a 1.01M 1.92M 1M 977K 941K 948K 857K 800K 764K 35.74M 377K 456K 26.34M 35.95M 25.51M 17.34M 12.86M
Gross Profit
n/a -1.01M 1.92M -1M -977K -941K -948K -857K -800K -764K -250.82M -377K 214.62M 292.51M 154.06M 110.23M 75.59M 30.96M
Operating Income
-211.7M -221.56M -189.93M -178.17M -333.77M -183.24M -153.71M -110.55M -94.01M -77.78M -213.41M -67.64M -197.11M -89.77M -50.88M -139.95M -171.89M -235.67M
Interest Income
n/a 4.21M 6.29M 5.65M 5.1M 4.3M 5.7M 3.77M 4.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-197.89M -221.07M -186.79M -160.36M -319.59M -178.94M -145.97M -105.86M -88.17M -69.55M -215.25M -67.64M -197.18M -89.78M -49.43M -174.53M -206.81M -261.5M
Net Income
-198.15M -221.68M -186.84M -160.3M -319.77M -179.5M -144.76M -102.57M -90.35M -70.49M -201.11M -68.85M -203.29M -97.03M -51.89M -171.82M -210.62M -264.97M
Selling & General & Admin
27.33M 33.98M 22.46M 20.56M 18.95M 27.27M 17.95M 15.03M 14.52M 14.32M 76.37M 14.79M 20.02M 19.68M 9.06M 8.52M 170.06M 159.52M
Research & Development
184.37M 187.58M 167.47M 157.61M 314.82M 155.97M 134.81M 95.52M 79.49M 63.46M 137.04M 52.84M 177.09M 70.1M 41.82M 46.97M 77.43M 46.35M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.84M n/a -67K -4K 1.45M -5K n/a n/a
Operating Expenses
211.7M 221.56M 189.93M 178.17M 333.77M 183.24M 152.76M 110.55M 94.01M 77.78M 213.41M 67.64M 197.11M 89.77M 50.88M 55.49M 247.49M 266.63M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -948K n/a n/a n/a 1.16M n/a n/a n/a n/a n/a 160.14M 149.61M
Cost & Expenses
211.7M 221.56M 189.93M 178.17M 333.77M 183.24M 153.71M 110.55M 94.01M 77.78M 213.41M 67.64M 197.11M 89.77M 50.88M 55.49M 264.82M 279.5M
Income Tax Expense
261K 609K 48K -59K 177K 569K -1.21M -3.29M 2.18M 939K -14.14M 1.22M 6.11M 7.25M 2.46M -1.13M 4.35M 3.82M
Shares Outstanding (Basic)
102.37M 101.94M 101.06M 94.37M 87.77M 81.6M 79.93M 68.32M 68.25M 68.21M 60.86M 39.37M 35.82M 35.82M 35.82M 39.37M 65.11M 48.49M
Shares Outstanding (Diluted)
102.37M 101.94M 101.06M 94.37M 87.77M 81.6M 79.93M 68.32M 68.25M 68.21M 60.86M 39.37M 35.82M 35.82M 35.82M 39.37M 65.11M 48.49M
EPS (Basic)
-1.94 -2.17 -1.85 -1.7 -3.64 -2.2 -1.81 -1.5 -1.32 -1.03 -3.3 -1.75 -5.67 -2.71 -1.45 -1.52 -3.23 -4.27
EPS (Diluted)
-1.94 -2.17 -1.85 -1.7 -3.64 -2.2 -1.81 -1.5 -1.32 -1.03 -3.3 -1.75 -5.67 -2.71 -1.45 -1.52 -3.23 -4.27
EBITDA
-211.7M -221.56M -176.57M -176.17M -331.82M -181.79M -151.82M -109.01M -92.18M -76.13M -213.07M -67.26M -196.69M -89.52M -50.2M -55.27M -56.02M -56.02M
EBIT
-197.89M -221.07M -186.79M -178.17M -333.77M -183.24M -153.71M -110.55M -94.01M -77.78M -215.25M -67.64M -197.11M -89.77M -50.88M -55.49M -56.26M -56.26M
Depreciation & Amortization
n/a 2.25M 2.46M 1.99M 977K 941K 1.89M 1.54M 1.83M 764K 344K 377K 415K 250K 685K 226K 241K 241K